Crissa Bennett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Crissa Bennett has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Amy Oreskovic
Department of Bioengineering, University of Washington, Seattle, Washington, USA
2 shared publications - Barry R. Lutz
Department of Bioengineering, University of Washington, Seattle, WA, USA
2 shared publications Daniel Leon
Department of Bioengineering, University of Washington, Seattle, WA, USA
2 shared publications- Enos C. Kline
Department of Bioengineering, University of Washington, Seattle, WA, USA
2 shared publications - Ian T. Hull
Department of Bioengineering, University of Washington, Seattle, WA, USA
2 shared publications - Jack Henry Kotnik
Department of Bioengineering, University of Washington, Seattle, WA, USA
2 shared publications
Latest Publications
- Open Access
- 17 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (51) , eabj1281
Harmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection
A unique four-plexed RT-LAMP test kit operated by health workers can provide faster, more sensitive results than laboratory tests.
- 17 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (51) , eabj1281
Open AccessHarmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection
A unique four-plexed RT-LAMP test kit operated by health workers can provide faster, more sensitive results than laboratory tests.
- Open Access
Harmony COVID-19: a ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection
RNA amplification tests allow sensitive detection of SARS-CoV-2 infection, but their complexity and cost are prohibitive for expanding COVID-19 testing. We developed “Harmony COVID-19”, a point-of-care test using inexpensive consumables, ready-to-use reagents, and a simple device that processes up to 4 samples simultaneously. Our lyophilized reverse-transcription, loop-mediated isothermal amplification (RT-LAMP) can detect as little as 15 SARS-CoV-2 RNA copies per reaction, and it can report as early as 17 min for samples with high viral load (2 x 10 5 RNA copies per reaction). Analysis of RNA extracted from clinical nasal specimens (n = 101) showed 95% concordance with RT-PCR, including 100% specificity in specimens positive for other viruses and bacteria. Analysis of contrived samples in the nasal matrix showed detection of 92% or 100% in samples with ≥20 or ≥100 particles per reaction, respectively. Usability testing showed 95% accuracy by healthcare workers operating the test for the first time. ONE SENTENCE SUMMARY: Harmony COVID-19: point-of-care SARS-CoV-2 RNA detection
Open AccessHarmony COVID-19: a ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection
RNA amplification tests allow sensitive detection of SARS-CoV-2 infection, but their complexity and cost are prohibitive for expanding COVID-19 testing. We developed “Harmony COVID-19”, a point-of-care test using inexpensive consumables, ready-to-use reagents, and a simple device that processes up to 4 samples simultaneously. Our lyophilized reverse-transcription, loop-mediated isothermal amplification (RT-LAMP) can detect as little as 15 SARS-CoV-2 RNA copies per reaction, and it can report as early as 17 min for samples with high viral load (2 x 10 5 RNA copies per reaction). Analysis of RNA extracted from clinical nasal specimens (n = 101) showed 95% concordance with RT-PCR, including 100% specificity in specimens positive for other viruses and bacteria. Analysis of contrived samples in the nasal matrix showed detection of 92% or 100% in samples with ≥20 or ≥100 particles per reaction, respectively. Usability testing showed 95% accuracy by healthcare workers operating the test for the first time. ONE SENTENCE SUMMARY: Harmony COVID-19: point-of-care SARS-CoV-2 RNA detection